Steven Cohen’s ProQR Therapeutics PRQR Stock Holding History

Steven Cohen’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.2K	Sell	50,652 -705,190	-93%	-$1.16M	﹤0.01%	3699
2026 Q1	$1.22M	Sell	755,842 -57,808	-7%	-$94.8K	﹤0.01%	2627
2025 Q4	$1.64M	Buy	813,650 +63,650	+8%	+$149K	﹤0.01%	2593
2025 Q3	$1.6M	Hold	750,000	–	–	﹤0.01%	1536
2025 Q2	$1.53M	Hold	750,000	–	–	﹤0.01%	1412
2025 Q1	$998K	Sell	750,000 -741,275	-50%	-$1.58M	﹤0.01%	1448
2024 Q4	$3.95M	Buy	+1,491,275	New	+$4.74M	0.01%	1026
2022 Q1	–	Sell	-461,000	Closed	-$3.69M	–	1341
2021 Q4	$3.69M	Buy	461,000 +3,100	+0.7%	+$23.6K	0.01%	733
2021 Q3	$3.83M	Buy	+457,900	New	+$2.99M	0.02%	709
2021 Q2	–	Sell	-1,521,800	Closed	-$10.1M	–	1129
2021 Q1	$10.1M	Buy	+1,521,800	New	+$7.78M	0.05%	424
2015 Q3	–	Sell	-100	Closed	-$2K	–	879
2015 Q2	$2K	Sell	100 -2,400	-96%	-$45.2K	﹤0.01%	701
2015 Q1	$55K	Buy	+2,500	New	+$51.6K	﹤0.01%	665

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Steven Cohen's PRQR Position: Q2 2026 in Review

Steven Cohen reduced its ProQR Therapeutics (PRQR) stake by 93% in Q2 2026, selling an estimated $1.16M and leaving 50,652 shares worth $94.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

Steven Cohen first reported a position in PRQR in Q1 2015 and has held it in 12 quarters since. The position peaked at $10.1M in Q1 2021. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

Steven Cohen held 50,652 shares of ProQR Therapeutics worth $94.2K as of Q2 2026.
Steven Cohen sold 705,190 ProQR Therapeutics shares in Q2 2026, an estimated $1.16M.
ProQR Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3699 holding.
Steven Cohen first reported a position in ProQR Therapeutics in Q1 2015 and has held it in 12 quarters since.
Steven Cohen's ProQR Therapeutics position peaked at $10.1M in Q1 2021.
70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.